BOSTON and TEL AVIV, Israel — September 17, 2025 — Leads & Copy — Mana.bio has launched Mina™, a free large language model (LLM) for lipid nanoparticles (LNPs), dubbed a “ChatGPT for LNPs.” The company said the new tool will accelerate scientific discovery and advance gene therapy and RNA-based medicines.
Mana.bio co-founder and CEO Yogev Debi said AI has the potential to transform biology and that Mina will open a new chapter in how science is done, accelerating discovery and bridging the gap between bench and bedside.
Mina offers predictive modeling, curated data retrieval, formulation optimization, and exploration of public data to scientists in RNA delivery and therapeutics development.
While Mana.bio retains exclusive access to its advanced models and datasets, it is open to collaborating with partners to leverage Mina’s full capabilities.
Media Contact: info@mana.bio
Source: Mana.bio
